McMaster's Stem Cell and Cancer Research Institute (SCC-RI) explores the underlying cellular and molecular origins that initiate human cancer by employing human stem cells as a model system. The Institute's impressive shared facilities are designed to help mitigate the high cost of human stem cell research that has made entry into the field almost prohibitive for investigators in Canada.
On the cutting edge of human stem cell research, our team of scientists integrates expertise in epigenetics, signalling pathways, neural cancer stem cells, human leukemia and pluripotent stem cells. Our ground-breaking research complements the efforts of other stem cell programs and centres in Canada and around the world.
With its particular focus in human stem cell research, the SCC-RI provides interested graduate students and postdoctoral fellows an exciting opportunity to pursue this specialized training in Canada. The Institute will also provide an open forum to educate the public about this important research and work with sectors developing ethical guidelines and policy for therapeutic applications to assure Canadians will receive the best health care possible.
The promise of discovering potential treatments for catastrophic diseases like autism and schizophrenia is being explored by Karun Singh at McMaster University's Stem Cell and Cancer Research Institute (SCC-RI).
A neuroscientist and the institute's newest recruit, his pioneering research is concentrating on uncovering underlying genetic defects inside the brains of people with these, and other neurological disorders, such as Alzheimer's.
Hamilton research on how to stop cancer from spreading to the brain has been named one of the most promising studies funded by the Canadian Cancer Society in 2013.
McMaster University researcher Dr. Sheila Singh hopes her work over the next five to ten years will turn one of the most fatal forms of cancer into a treatable disease.
Eva Szabo, a researcher with the Stem Cell and Cancer Research Institute, was awarded a Canada Research Chair in Metabolism in Human Stem Cells and Cancer Development.